ReviewPLoS pathogens2014
Inhibitors of peptidyl proline isomerases as antivirals in hepatitis C and other viruses.
Rob Striker, Andrew Mehle
Open access · goldAbstract readReview
In one paragraphReview in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
2 authors at 2 institutions in 1 country.
Rob StrikerDepartment of Medicine, W. S. Middleton Memorial Veteran's Association, Madison, Wisconsin, United States of America; Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America; Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Andrew MehleDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
University of Wisconsin–Madison · USWilliam S. Middleton Memorial Veterans Hospital · US
Funding
Mentoring a Cancer Genetics ProgramP20GM103518 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI DEININGER, PRESCOTT L. · 2012 to 2013
$4.3MEpstein Barr virus antisense transcriptionR01AI106676 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2014 to 2018
$1.9MIntercellular communication in Epstein Barr virus reactivationR01AI101046 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2012 to 2016
$1.9MRole of the cellular microRNA, miR-155, in EBV type III latency signalingR01CA138268 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2009 to 2013
$1.5MHuman cytomegalovirus in the promotion of glioblastoma multiforme pathogenesisF30CA177267 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI STRONG, MICHAEL JAMES · 2013 to 2016
$129kNCI NIH HHS F30CA177267NCI NIH HHS R01CA138268NIAID NIH HHS R01AI101046NIAID NIH HHS R01AI106676NIGMS NIH HHS P20GM103518
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Antiviral AgentsHepacivirusHepatitis CHumansPeptidylprolyl IsomeraseAntiviral AgentsPeptidylprolyl Isomerase
Identifiers
PMID25375953
PMCPMC4223064
OpenAlexW2004236076
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390